VC  Bay City Capital

http://www.baycitycapital.com





     Office Locations:

750 Battery Street, Suite 400
San Francisco, CA 94111
Phone: 415-676-3830
Fax: 415-837-0503

 

Stages:

  • Early
  • Seed


 

Industries:

  • Food & Agriculture
  • Life Sciences & Healthcare

  •  

    Description:

    Bay City Capital was established in 1997 as an equal partnership between The Craves Group, LLC and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry and related activities. Since that date, the firm has managed five investment funds representing $1.3 billion in committed capital and invested in over 90 companies. Five of these funds are general life sciences funds and three are sector funds. In addition, Bay City serves as the investment advisor for The North American Nutrition and Agribusiness Fund, LP (NANAF), a sector fund, representing $111 million in committed capital. Bay City Capital seeks to maintain a balanced and diversified portfolio across the various life sciences sectors and with companies at various stages of development.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Andrew Han Analyst
    Carl Goldfischer MD Managing Director
    David Beier JD Managing Director
    Dayton Misfeldt Managing Director
    Fred Craves PhD Managing Director

     

    Portfolio companies include:


      Antriabio
        web link


      Cadence Pharmaceuticals
        web link


      Civitas Therapeutics
        web link


      Conatus Pharmaceuticals
        web link


      Cydan
        web link


      Dermira
        web link


      EnteroMedics
        web link


      Epizyme
        web link


      Fabric Genomics
        web link


      Hyperion Therapeutics
        web link


      Idev Technologies
        web link


      Imara
        web link


      Interleukin Genetics
        web link


      Iterum Therapeutics
        web link


      Kezar Life Sciences
        web link


      Madrigal Pharmaceuticals
        web link


      Nevro
        web link


      PharmAkea Therapeutics
        web link


      Presidio Pharmaceuticals
        web link


      PTC Therapeutics
        web link


      Reset Therapeutics
        web link


      Sunesis
        web link


      SynGen
        web link


      Twist Bioscience
        web link


      Vivaldi Biosciences
        web link


      Vtesse
        web link


      Xeris Pharmaceuticals
        web link


     

    Recent News: